Critic at Large

» techniques, cell & molecular biology and funding

Most Recent

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By , and | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: Enhanced Enhancers

Enhanced Enhancers

By | November 1, 2014

The recent discovery of super-enhancers may offer new drug targets for a range of diseases.

0 Comments

image: Remaking Nature

Remaking Nature

By | August 1, 2013

Synthetic biologists need to work together with conservationists to understand the environmental consequences of this new technology.

6 Comments

image: Food for Thought

Food for Thought

By | June 1, 2012

Plant research remains grossly underfunded, despite the demand for increased crop production to support a growing population.

6 Comments

image: Avoiding Animal Testing

Avoiding Animal Testing

By | December 1, 2011

Advances in cell-culture technologies are paving the way to the complete elimination of animals from the laboratory.

82 Comments

image: Vive la Différence

Vive la Différence

By | September 1, 2011

Measuring how individual cells differ from each other will enhance the predictive power of biology.

6 Comments

image: Desperately Seeking Radioisotopes

Desperately Seeking Radioisotopes

By | July 1, 2011

New strategies are needed to address the current and future shortages of radioisotopes that threaten medical research and treatment.

21 Comments

image: Hard and Harder

Hard and Harder

By | June 5, 2011

The path to eradicating malaria in Africa involves much more than just a vaccine.

18 Comments

image: Another Revolution Needed?

Another Revolution Needed?

By | March 1, 2011

Counting the many plagues that threaten research in the Middle East and North Africa region

1 Comment

image: At the Tipping Point

At the Tipping Point

By | February 1, 2011

Data standards need to be introduced—now.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech